Facebook Instagram Twitter RSS Feed PodBean Back to top on side

Novel seleno-hydantoin palladium(II) complex – antimigratory, cytotoxic and prooxidative potential on human colon HCT-116 and breast MDA-MB-231 cancer cells

In: General Physiology and Biophysics, vol. 36, no. 2
Marko Živanović - Jelena Košarić - Biljana Šmit - Dragana Šeklić - Radoslav Pavlović - Snežana Marković
Detaily:
Rok, strany: 2017, 187 - 196
O článku:
Selenium and palladium containing compounds separately exert multifunctional effects on cells. While selenium containing compounds usually exert antioxidative properties, palladium(II) containing compounds are cytotoxic and prooxidative. Here we investigated biological effects of bicyclic seleno-hydantoin cis-7a-ethyl-5-methyl-5-phenylselanylmethyl-tetrahydro-pyrrolo[1,2-c]imidazole-1,3-dione (Hid-Se), and its palladium(II) complex, trans-bis-(cis-7a-ethyl-5-methyl-5-phenylselanylmethyl-tetrahydro-pyrrolo[1,2-c]imidazole-1,3-dionato) palladium(II) chloride ((Hid-Se)2Pd) on human colon HCT-116 and breast MDA-MB-231 cancer cell lines. Hid-Se and (Hid-Se)2Pd showed prooxidative and cytotoxic character. In all performed experiments (Hid-Se)2Pd proved to be more active, i.e. this substance exerted greater prooxidative effect, cytotoxicity and influence on cell migration potential. Even though Hid-Se and (Hid-Se)2Pd enhanced migration of HCT-116 cells, very important feature of these substances is the strong antimigratory potential on metastatic MDA-MB-231 cells.
Ako citovať:
ISO 690:
Živanović, M., Košarić, J., Šmit, B., Šeklić, D., Pavlović, R., Marković, S. 2017. Novel seleno-hydantoin palladium(II) complex – antimigratory, cytotoxic and prooxidative potential on human colon HCT-116 and breast MDA-MB-231 cancer cells. In General Physiology and Biophysics, vol. 36, no.2, pp. 187-196. 0231-5882.

APA:
Živanović, M., Košarić, J., Šmit, B., Šeklić, D., Pavlović, R., Marković, S. (2017). Novel seleno-hydantoin palladium(II) complex – antimigratory, cytotoxic and prooxidative potential on human colon HCT-116 and breast MDA-MB-231 cancer cells. General Physiology and Biophysics, 36(2), 187-196. 0231-5882.